Re: RESEARCH WHI: further analysis of venous thrombosis risk w...

[Guest guest]

: Have you heard any reports if using evista can cause any thrombosis? I

use it and I am overweight and I am wondering if this puts me at risk.

Thanks.

Colletti

Anjillah@...

[Guest guest]

: Have you heard any reports if using evista can cause any thrombosis? I

use it and I am overweight and I am wondering if this puts me at risk.

Thanks.

Colletti

Anjillah@...

[Guest guest]

Yes, , Evista is associated with an increased incidence of

thromboembolic events.

From RxList.com:

" Venous Thromboembolic Events: An analysis of EVISTA-treated women across

all placebo-controlled clinical trials showed an increased risk of venous

thromboembolic events defined as deep vein thrombosis, pulmonary embolism,

and retinal vein thrombosis. The greatest risk for thromboembolic events

occurs during the first 4 months of treatment. EVISTA should be discontinued

at least 72 hours prior to and during prolonged immobilization (e. g.,

post-surgical recovery, prolonged bed rest), and EVISTA therapy should be

resumed only after the patient is fully ambulatory. Patients should be

advised to avoid prolonged restrictions of movement during travel. The

risk-benefit balance should be considered in women at risk of thromboembolic

disease for other reasons, such as congestive heart failure and active

malignancy. "

http://www.rxlist.com/cgi/generic/raloxif_wcp.htm

" EVISTA is contraindicated in women with active or past history of venous

thromboembolic events, including deep vein thrombosis, pulmonary embolism,

and retinal vein thrombosis. "

http://www.rxlist.com/cgi/generic/raloxif_od.htm

>From: ANJILLAH@...

>Reply-

>Matsumura_Clan@...,

>Subject: Re: [ ] RESEARCH WHI: further analysis of venous

>thrombosis risk w...

>Date: Tue, 28 Dec 2004 17:45:53 EST

>

>

>: Have you heard any reports if using evista can cause any thrombosis?

>I

>use it and I am overweight and I am wondering if this puts me at risk.

>Thanks.

> Colletti

>Anjillah@...

>

>

>

[Guest guest]

Yes, , Evista is associated with an increased incidence of

thromboembolic events.

From RxList.com:

" Venous Thromboembolic Events: An analysis of EVISTA-treated women across

all placebo-controlled clinical trials showed an increased risk of venous

thromboembolic events defined as deep vein thrombosis, pulmonary embolism,

and retinal vein thrombosis. The greatest risk for thromboembolic events

occurs during the first 4 months of treatment. EVISTA should be discontinued

at least 72 hours prior to and during prolonged immobilization (e. g.,

post-surgical recovery, prolonged bed rest), and EVISTA therapy should be

resumed only after the patient is fully ambulatory. Patients should be

advised to avoid prolonged restrictions of movement during travel. The

risk-benefit balance should be considered in women at risk of thromboembolic

disease for other reasons, such as congestive heart failure and active

malignancy. "

http://www.rxlist.com/cgi/generic/raloxif_wcp.htm

" EVISTA is contraindicated in women with active or past history of venous

thromboembolic events, including deep vein thrombosis, pulmonary embolism,

and retinal vein thrombosis. "

http://www.rxlist.com/cgi/generic/raloxif_od.htm

>From: ANJILLAH@...

>Reply-

>Matsumura_Clan@...,

>Subject: Re: [ ] RESEARCH WHI: further analysis of venous

>thrombosis risk w...

>Date: Tue, 28 Dec 2004 17:45:53 EST

>

>

>: Have you heard any reports if using evista can cause any thrombosis?

>I

>use it and I am overweight and I am wondering if this puts me at risk.

>Thanks.

> Colletti

>Anjillah@...

>

>

>